HealthTech

How 1mg is changing under Tata Digital

Supriya Roy

Madhav Chanchani

July 27, 2022 | 11 Min Read

In a crowded market comprising conglomerates, MNCs and cash-rich startups, 1mg has spent the last year improving its supply chain and expanding. The Tata Digital-owned company is now raising more capital, but will it be enough to take on the heavily funded Pharmeasy and Reliance-backed Netmeds?

About two years ago, just when the first wave of the Covid-19 pandemic sparked a spike in demand for deliveries by online pharmacy players, 1mg Technologies hit the market to raise a new round of funding.

When it started out, 1mg was not meant to be an online pharma company. At least, that was not founder Prashant Tandon’s and then co-founder Sameer Maheshwari’s original business idea back in 2011. The startup was an offshoot of e-commerce platform Healthkart, best known for selling supplements. It was known as Healthkartplus – an online marketplace for health devices, personal care, fitness and nutrition supplements, sports nutrition, eye-care and so on, having tie-ups with top distributors and retailers in different cities.

But in 2015, Tandon, a McKinsey consultant with an MBA from Stanford, decided to demerge the business.

Corporate

Access unlimited content at a special discounted rate. Trusted by top VC’s and leading organizations, we provide bulk subscriptions for groups of 30+. Contact us for more details

Campus

Top educational institutions have collaborated with us for campus-wide subscriptions. For bulk campus-wide access, please get in touch.

Join our community of 100,000+ top executives, VCs, entrepreneurs, and brightest student minds

Trusted by the best

Karthik Reddy

Blume Ventures

The CapTable brings a refreshing set of insights for us at the Blume team, highlighting stories that bring together the underlying business and founders with that of investors' journeys with these startups. It's an important perspective that very few bring to startup ecosystem enthusiasts.

Latest Articles

Inside the fight to reclaim ‘ORS’ from misuse

The battle over ORS-branded beverages exposes the cracks in India’s food regulation and how companies can exploit medical trust. A paediatrician’s complaint has forced the FSSAI and courts to confront a long-ignored grey zone.

Anuj Suvarna

From ice cream to protein, why Heritage Foods wants to bet on macros

Rather than building its own protein line, 33-year-old dairy company Heritage Foods is buying one. Get-A-Way’s acquisition signals where it sees its next scoop of growth—an indulgent ice cream with protein on top. Will the bet pay off?

Shivani Verma

India's auto boom rides on workers who can't get a real job

The CapTable’s analysis of the Annual Survey of Industries shows that half a million contract workers who power the country’s car factories earn half the pay of their permanent counterparts with no benefits, no unions, and contracts that reset every few months

Parvathi Benu

India’s Rs 40,000 crore fight for a lifeline when disaster strikes

The home ministry seeks premium spectrum to build an emergency network that connects police, firefighters and rescue teams. Four telecom giants will run trials across ten regions to make it happen.

Pratap Vikram Singh

How Ultrahuman is battling to break its dependency on the smart ring and the US

Once touted as India’s answer to Finnish wearable major Oura, Ultrahuman now faces its toughest test yet—a US sales ban on its flagship product, high replacement rates, and pressure to prove it’s more than a one-product, one-market company.

Shivani Verma

Convinced that The Captable stories and insights
will give you the edge?

Convinced that The Captable stories
and insights will give you the edge?

Subscribe Now

Stories

Explore